AB 2233 revises California law governing insurer coverage of behavioral health treatment for pervasive developmental disorder and autism. The bill spells out who may deliver authorized services, requires written treatment plans with measurable goals, mandates periodic review of those plans, and directs insurers to maintain networks that include qualified autism service providers and supervised professionals.
The bill also limits insurer practices that interrupt access: it prohibits requiring an insured who previously received an autism diagnosis to undergo a ‘‘rediagnosis’’ as a condition of maintaining coverage and forbids insurers from discontinuing existing treatment while a rediagnosis is pursued. At the same time, AB 2233 preserves insurers’ use of utilization review, prior authorization, and other management tools and excludes certain specialized policies and Medi-Cal plans from its scope.
At a Glance
What It Does
Imposes statutory standards for coverage of behavioral health treatment for autism, including required treatment-plan content, a minimum review cadence, and a prohibition on forfeiture of authorized hours within a six‑month authorization period. It requires insurers to maintain an adequate network that includes qualified autism service providers and supervised professionals, and it prohibits insurers from conditioning continued coverage on a rediagnosis for previously diagnosed insureds.
Who It Affects
State-regulated health insurers and health plans that issue, amend, or renew policies in California, qualified autism service providers and the professionals/paraprofessionals they supervise, and Californians with autism and their caregivers seeking behavioral health treatment. The text excludes Medi‑Cal managed care and narrow specialty policies that do not cover behavioral health.
Why It Matters
The bill narrows administrative barriers that have delayed or interrupted access to applied behavior analysis and similar interventions while creating clearer standards for treatment plans and provider roles. For insurers and plan managers it raises network and documentation obligations that will affect contract negotiations, utilization-management workflows, and claims administration.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
AB 2233 sets a statutory framework for how commercial health insurance policies in California must cover behavioral health treatment for pervasive developmental disorder and autism. Rather than leaving key elements to rate filings or regulatory guidance alone, the bill codifies the kinds of providers who may prescribe and deliver care, the structure and content of a treatment plan, and the cadence for clinical review.
It draws on existing cross‑references to Section 10144.5 and to the Welfare and Institutions Code to tie clinical expectations to previously established state practice.
The bill defines treatment broadly to include applied behavior analysis and evidence‑based behavioral interventions, but conditions coverage on a treatment plan developed or prescribed by appropriately licensed clinicians and implemented by a qualified autism service provider or supervised professional/paraprofessional. Treatment plans must set measurable goals and a timeline, be reviewed at least every six months, and be made available to the insurer when requested.
Importantly, AB 2233 prohibits insurers from imposing weekly caps or similar limits that cause an insured to forfeit approved hours during the six‑month authorization window; authorized hours must remain available throughout that period.On administrative points, AB 2233 prohibits insurers from requiring a new diagnosis as a prerequisite for continuing previously authorized autism behavioral treatment, while allowing treating providers to reevaluate or prescribe a rediagnosis at their professional discretion. The bill distinguishes ‘‘rediagnosis’’ from routine utilization review: insurers may continue to perform utilization review, prior authorization, case management, and cost sharing, but they may not discontinue existing treatment while awaiting a rediagnosis.
The statute also requires insurers to maintain network adequacy that includes qualified autism service providers, while permitting selective contracting within those requirements.The statute explicitly does not apply to Medi‑Cal policies or to narrowly tailored specialty products that do not cover behavioral health services, and it preserves existing obligations under Section 10144.5. The text also includes an express caveat that it cannot require benefits that exceed federal essential health benefits once those federal EHB rules are finalized, which affects the outer bounds of coverage that state law can compel.
The Five Things You Need to Know
The bill forbids health insurers from requiring a rediagnosis for an insured previously diagnosed with pervasive developmental disorder or autism on or after January 1, 2026.
Treatment plans must have measurable goals, be approved by a qualified autism service provider, and be reviewed at least once every six months.
Insurers may not impose weekly caps or limitations that cause forfeiture of authorized treatment hours during the six‑month authorization period; authorized hours must remain available throughout that period.
The statute requires insurers to maintain adequate networks that include qualified autism service providers and supervised professionals, but it allows selective contracting within that standard.
AB 2233 preserves utilization review, prior authorization, cost sharing, and other management tools for insurers, and it excludes Medi‑Cal and certain specialized policies from its coverage requirements.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Coverage baseline and federal EHB constraint
Subdivision (a) ties the requirement to provide behavioral health treatment for autism to earlier state law (Section 10144.5) and includes a savings clause: once federal rulemaking fixes the scope of essential health benefits (EHB), the state will not be able to force insurers to provide benefits beyond those federal minimums. Practically, that means the bill sets an expectation of coverage at the state level but recognizes a legal ceiling if federal EHB determinations limit mandated benefits. The provision also cross‑references non‑duplication for services already available under state welfare or education law, which preserves the traditional carve‑outs for Medi‑Cal and educational obligations.
Network adequacy requirement for autism service capacity
This section requires insurers to maintain an adequate network that includes qualified autism service providers who can supervise or employ the professionals and paraprofessionals delivering behavioral interventions. The obligation is operational: plans will need to demonstrate provider capacity and access (provider directories, contracting, and appointment wait times) consistent with Article 6 of the applicable California regulations. The text also permits selective contracting, so insurers retain flexibility to negotiate rates and credentialing terms while still meeting an access standard.
Prohibition on rediagnosis conditions and procedural safeguards
Subdivision (c) creates a clear prohibition: beginning January 1, 2026, insurers may not require a person who already has an autism diagnosis to undergo a new diagnostic process to keep receiving behavioral health treatment. The clause preserves clinician discretion to reevaluate a patient and allows providers to prescribe a rediagnosis when clinically appropriate, but it forbids insurers from using a pending rediagnosis as a reason to stop or delay treatment. The subdivision also clarifies that utilization review is still permitted, but treats it as distinct from rediagnosis, which has implications for how insurers structure clinical-review pathways and appeals.
Definitions and treatment‑plan mechanics
Subdivision (d) supplies operational definitions—who counts as a qualified autism service provider, professional, or paraprofessional—and sets out the substantive content of an acceptable treatment plan. A plan must be prescribed or developed by licensed clinicians, include measurable goals and timelines, and be reviewed at least twice yearly. The section further obliges insurers not to impose restrictions (for example, weekly caps) that would cause the forfeiture of authorized hours during the authorization period and requires that treatment plans be available to the insurer on request, which creates documentation and privacy considerations for providers and plans.
Scope exclusions
Subdivision (e) carves out a set of insurance products from the statute — policies that explicitly do not cover mental or behavioral health services and certain limited‑benefit products (accident‑only, specified disease, hospital indemnity, and Medicare supplements) — and also excludes Medi‑Cal plans. That narrows the bill’s practical reach to commercially regulated products that cover behavioral health, rather than to every contractual arrangement that might touch health services in California.
Permitted utilization management and cost‑sharing tools
Subdivision (g) reconciles the access protections with insurer tools: health plans may still use case management, network providers, utilization review, prior authorization, copayments, and other cost‑sharing in delivering benefits required by the statute. The provision therefore preserves insurers’ discretion to manage clinical appropriateness and control costs, while being constrained by the bill’s specific prohibitions (for example, no discontinuation of treatment pending rediagnosis and no forfeiture of authorized hours).
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Insured Californians with autism and their families — they gain clearer statutory protections against coverage interruption, may retain authorized hours across an authorization window, and have a defined treatment‑plan standard to support claims and appeals.
- Qualified autism service providers and supervised professionals — clearer definitions and a statutory expectation of network inclusion can increase demand for credentialed providers and create a more predictable billing environment for ABA and other behavioral interventions.
- Advocacy groups and care coordinators — the requirement that treatment plans be measurable and reviewed at least every six months supplies structured documentation that advocates can use in appeals and coordination with educational and social services.
Who Bears the Cost
- State‑regulated health insurers and health plans — they face increased network‑adequacy obligations, documentation and claims-processing work, and potential higher utilization if access barriers are lowered.
- Plan administrators and utilization‑management teams — systems will need updates to accept treatment plans, track six‑month reviews, prevent forfeiture of authorized hours, and ensure continuity of care while distinguishing utilization review from rediagnosis.
- Regulatory agencies (e.g., Department of Managed Health Care and California Department of Insurance) — enforcing network adequacy, compliance with treatment‑plan requirements, and dispute resolution could increase oversight workload and require new guidance.
Key Issues
The Core Tension
The bill pits uninterrupted access to evidence‑based behavioral treatments for autistic individuals against insurers’ ability to manage clinical appropriateness and costs: guaranteeing continued treatment and prohibiting forfeiture of authorized hours reduces administrative barriers for families but constrains traditional insurer tools for utilization control, leaving regulators and payers to reconcile access protections with program integrity and fiscal sustainability.
AB 2233 balances access protections with retained insurer management tools, but the balance leaves open several implementation questions. The federal essential health benefits caveat in subdivision (a) means the ultimate scope of mandatory benefits could change depending on federal EHB rulemaking; insurers and regulators will need to translate any future EHB determinations into which autism‑related services the state may still compel.
The bill also preserves utilization review and prior authorization, yet it forbids stopping care while a rediagnosis is obtained—insurers will need clear protocols to continue payment streams during clinical re‑assessment without undermining their ability to confirm medical necessity.
Operationally, the requirement that authorized hours remain available across a six‑month authorization period eliminates a common insurer mechanism (weekly or sessional caps) but raises administrative questions about how to track, carry forward, or audit hours in claims systems. Requiring treatment plans to be available on request improves transparency but creates privacy and data‑handling burdens for providers and plans and raises the risk of disputes over the sufficiency of documentation.
Finally, the statute references several other codes (Welfare and Institutions Code, Education Code, Business and Professions Code) to limit duplication, but in practice coordination among insurers, Medi‑Cal, and educational authorities will be necessary to avoid gaps or overlapping responsibility for care.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.